These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3331803)

  • 21. Preliminary results of low-dose cyclosporin A in pediatric renal transplantation.
    Nevins TE; Knaak M; So SK; Chavers B; Melvin T; Simmons RL; Mauer SM; Najarian JS
    Int J Pediatr Nephrol; 1986; 7(2):91-4. PubMed ID: 3522458
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunosuppression following cardiac transplantation.
    Copeland JG; Emery RW; Levinson MM; Icenogle T
    Contemp Anesth Pract; 1987; 10():233-40. PubMed ID: 3555997
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [After care of kidney transplant patients].
    Castro LA; Eigler J; Land W
    Internist (Berl); 1983 Sep; 24(9):510-6. PubMed ID: 6313541
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary polyamine levels are markers of altered T lymphocyte proliferation/loss and rejection in heart transplant patients.
    Womble JR; Larson DF; Copeland JG; Russell DH
    Transplant Proc; 1984 Dec; 16(6):1573-5. PubMed ID: 6390864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunologic diagnosis of orthotopic cardiac allograft rejection in dogs.
    Caves PK; Dong E; Morris RE; Shumway NE
    Transplant Proc; 1973 Mar; 5(1):745-8. PubMed ID: 4572136
    [No Abstract]   [Full Text] [Related]  

  • 27. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
    Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
    J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of Cyclosporin A on transplantation.
    Morris PJ
    Adv Surg; 1984; 17():99-127. PubMed ID: 6367397
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sudden death as the only manifestation of rejection in the heart transplant patient treated with cyclosporin A].
    Abadal ML; Ballester M; Cladellas M; Obrador D; Badía F; Rodríguez C; Bordes R; García-Moll M; Padró J; Arís A
    Rev Esp Cardiol; 1987; 40 Suppl 2():52-4. PubMed ID: 3331806
    [No Abstract]   [Full Text] [Related]  

  • 30. Are there indications for heterotopic heart transplantation today?
    Becerra E; Cooper DK; Novitzky D; Reichart B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2512-3. PubMed ID: 3274551
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of antirejection therapy.
    Schulak JA; Drevyanko TF
    Surgery; 1985 Aug; 98(2):330-7. PubMed ID: 3895543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acute rejection crisis by antilymphocyte globulins: a randomized prospective study in pediatric kidney transplantation.
    Broyer M; Niaudet P; Bijaoui M; Gagnadoux MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1886-8. PubMed ID: 3547894
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerance of peripheral veins to antithymocyte globulin after heart transplantation.
    Cantarovich M; Latter DA
    J Heart Lung Transplant; 1994; 13(4):737. PubMed ID: 7947896
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeted blood levels of cyclosporin for cardiac transplantation.
    Griffith BP; Hardesty RL; Trento A; Lee A; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Dec; 88(6):952-7. PubMed ID: 6389991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute rejection of the heart-lung allograft and methods of its detection.
    Griffith BP; Durham SJ; Hardesty RL; Trento A; Paradis IL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2527-30. PubMed ID: 3103298
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cyclosporin in heart transplant: a developing treatment].
    Ballester Rodés M; Pons Lladó G; Obrador Mayol D; Carreras Costa F; Cladellas Capdevila M; Abadal Berini ML; Amengual Guedán MJ; Bonnín Gubianas O; Padró Fernández JM; Arís A
    Med Clin (Barc); 1986 Apr; 86(14):600-3. PubMed ID: 3523068
    [No Abstract]   [Full Text] [Related]  

  • 37. Polyclonal antithymocyte serum: immune prophylaxis and rejection therapy in pediatric heart transplantation patients.
    Lebeck LK; Chang L; Lopez-McCormack C; Chinnock R; Boucek M
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S286-92. PubMed ID: 8312347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preformed lymphocytotoxic antibodies disappear following cyclosporine therapy.
    Novitzky D; Cooper DK; Du Toit E; Oudshoorn M; Langman E; Jacobs P
    J Heart Transplant; 1985 May; 4(3):362-3. PubMed ID: 3916509
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in the lymphocyte subpopulations in a patient with orthotopic transplant of the liver].
    Cavallini M; Marcellini M; Palumbo M; Sartorelli MR; Castaldo P; Giannone G; Ziparo V
    Minerva Chir; 1989 Jun; 44(12):1651-4. PubMed ID: 2671801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac transplantation with cyclosporine and steroids: medium and long-term results.
    Hakim M; Spiegelhalter D; English TA; Caine N; Wallwork J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):327-32. PubMed ID: 3291264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.